Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Basket Study of BMS-986504 in Combination With Pemetrexed for Metastatic Solid Tumors With MTAP Deletion

NCT07594626 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT07594626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07594626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Basket Study of BMS-986504 in Combination With Pemetrexed for Metastatic Solid Tumors With MTAP Deletion
Lead sponsor
Northwestern University
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 21, 2026
Completion date
December 9, 2030
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic biliary tract carcinoma, metastatic colon carcinoma, metastatic esophageal carcinoma, metastatic malignant digestive system neoplasm, metastatic malignant solid neoplasm, metastatic pancreatic carcinoma, stage iv colon cancer ajcc v8, stage iv pancreatic cancer ajcc v8